Of crucial importance in Survivin overexpression is its localisation, because nuclear Survivin indicates a good prognosis for recurrence-free survival in breast cancer, while cytoplasmic Survivin has a poorer outcome [13,50,52,53]. This evidence concerns the gene BIRC5 and breast cancer.